Back
Aligos Therapeutics, Inc. Stock Predictions
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
33
ALGS
Aligos Therapeutics, Inc.
Last Price:
$9.16
Seasonality Move:
-31.98%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atAligos Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Aligos Therapeutics, Inc. has on average historically fallen by 32.7% based on the past 5 years of stock performance.
-
Aligos Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Aligos Therapeutics, Inc. Stock Undervalued?The current Aligos Therapeutics, Inc. [ALGS] share price is $9.24. The Score for ALGS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Aligos Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Aligos Therapeutics, Inc. has on average historically fallen by 32.7% based on the past 5 years of stock performance.
Aligos Therapeutics, Inc. Stock Rating
Sell
33
Aligos Therapeutics, Inc. (ALGS)
is a Sell
Is Aligos Therapeutics, Inc. overpriced?
-
Aligos Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Aligos Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com
52-Week Data
52-Week High:
35.30
52-Week Low:
3.76
Prediction Charts
Market Cap:
56.9M
Price in USD:
9.24
Volume:
47.5K
Beta:
2.75
Technical Analysis
SMA50:
9.17
SMA100:
9.64
SMA200:
8.25
52-Wk Change:
-73.09%
Stock Predictions
-
Is Aligos Therapeutics, Inc. stock public?Yes, Aligos Therapeutics, Inc. is a publicly traded company.
-
What is the Aligos Therapeutics, Inc. stock quote today?The Aligos Therapeutics, Inc. stock price is 9.24 USD today.
-
How to buy Aligos Therapeutics, Inc. stock online?You can buy Aligos Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-19 | 10.32 | 10.68 | 11.04 | 10.32 |
| Dec-22 | 10.64 | 10.75 | 11.50 | 10.10 |
| Dec-24 | 9.95 | 10.52 | 10.69 | 9.81 |
| Dec-26 | 10.34 | 10.11 | 10.50 | 9.85 |
| Dec-29 | 9.99 | 9.65 | 10.01 | 9.33 |
| Dec-30 | 9.57 | 9.12 | 9.91 | 9.12 |
| Dec-31 | 9.01 | 9.32 | 9.60 | 9.00 |
| Jan-5 | 9.14 | 8.41 | 10.00 | 8.25 |
| Jan-6 | 8.35 | 8.76 | 8.90 | 8.35 |
| Jan-7 | 8.91 | 9.65 | 9.65 | 8.91 |
| Jan-8 | 9.65 | 10.33 | 10.49 | 9.61 |
| Jan-9 | 10.41 | 9.00 | 10.45 | 9.00 |
| Jan-12 | 9.00 | 8.71 | 9.07 | 8.39 |
| Jan-13 | 8.59 | 9.24 | 9.43 | 8.52 |
Aligos Therapeutics, Inc. Earnings
Aligos Therapeutics, Inc. Earnings Report: Per Share Aligos Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aligos Therapeutics, Inc. Forecast Revenue Growth
Aligos Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.73 per share.
* Aligos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.